PRISM Biotech
New York, February 20, 2024 - PRISM MarketView - Cybin Inc. (NYSE American: CYBN) has reported its unaudited financial results for its third quarter ended December 31, 2023 and highlighted positive Phase 2 topline efficacy and safety data for CYB003, in the treatment of ...

20 February 2024

PRISM Biotech
New York, February 19, 2024 - PRISM MarketView -The FDA has approved the first new frontline treatment for metastatic pancreatic cancer in more than a decade. This week, global biopharmaceutical company, Ipsen, announced that it had received regulatory approval for Onivy...

19 February 2024

PRISM Biotech
New York, February 16, 2024 - PRISM MarketView - The journey of progressing a drug molecule from concept to commercialization is a lengthy and intricate process, typically spanning 10-15 years. This period encompasses the initial discovery phase, through to clinical tria...

16 February 2024

PRISM Biotech
New York, February 15, 2024 - PRISM MarketView - Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company, provided an update on its Phase III clinical trial, Flamingo-01, focusing on GLSI-100, an immunotherapy aimed at preventing breast ca...

15 February 2024

PRISM Daily
New York, February 15, 2024 - PRISM MarketView - Village Farms International (Nasdaq: VFF) has begun construction on  its first indoor cannabis production facility in Drachten, Netherlands. The company plans to fund the build-out of the facility from cash on hand.

15 February 2024

PRISM Daily
New York, February 15, 2024 - PRISM MarketView - Today the megacap AI chipmaker Nvidia (NVDA) disclosed its stake in some smaller AI firms that has boosted shares for those associated with the disclosure.

15 February 2024

PRISM Daily
New York, February 15, 2024 - PRISM MarketView - As part of its partnership with award-winning Dutch seed bank, Paradise Seeds, global medicinal cannabis company, Clever Leaves Holdings (Nasdaq: CLVR), will develop and register high performance cannabis cultivars in Colo...

15 February 2024

PRISM Biotech
New York, February 15, 2024 - PRISM MarketView - Atara Biotherapeutics (Nasdaq: ATRA) has submitted an Investigational New Drug (IND) application to the FDA for the use of ATA3219 as a monotherapy for the treatment of systemic lupus erythematosus(SLE) with kidney involve...

15 February 2024

News
New York, February 14, 2024 - PRISM MarketView - Soluna Holdings, Inc. (NASDAQ: SLNH), a pioneer in developing green data centers, has ventured into the AI hosting market through a landmark co-location agreement with a GPU startup specializing in AI computing. This partn...

14 February 2024

PRISM Markets
New York, February 14, 2024 - PRISM MarketView - Inspira Technologies (Nasdaq: IINN), a pioneering medical technology company aiming to advance beyond traditional mechanical ventilators, has been granted the first-ever U.S. Patent for an orbiting blood oxygenation delive...

14 February 2024

49
50
51
52
53
54
55
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.